Friday, December 23, 2022
New Platform Director, Biological Sciences
Dr. JoAnne McLaurin is currently a senior scientist in Biological Sciences and the Hurvitz Brain Sciences Research Program at SRI and holds a Tier 1 Canada Research Chair in Alzheimer’s Disease Therapeutics.
Thursday, December 22, 2022
Driving and Dementia Roadmap: A new resource on a World Health Organization Global Dementia Platform
An online Canadian online resource about driving and dementia developed by a team of researchers, including Dr. Mark Rapoport at Sunnybrook, has been recognized as a dementia resource on a World Health Organization platform.
Friday, December 16, 2022
How proper use of a CPAP is linked to improved thinking in people with sleep apnea
A new study by Sunnybrook researchers has found that using continuous positive airway pressure (CPAP) therapy appropriately is linked with improved thinking and memory in patients with obstructive sleep apnea who have cognitive impairment.
Monday, December 12, 2022
COVID vaccine hesitancy associated with increased traffic crash risk
New Sunnybrook study suggests an underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents
Tuesday, December 6, 2022
Imaging study suggests Long COVID may impact brain physiology
The study team found that people who self-isolated with COVID-19 had lower cerebral blood flow compared to people who self-isolated with flu-like symptoms, but not COVID-19.
